ORIC PHARMACEUTICALS INC
NASDAQ: ORIC (Oric Pharmaceuticals, Inc.)
Kemas kini terakhir: 5 minit lalu11.39
0.41 (3.73%)
| Penutupan Terdahulu | 10.98 |
| Buka | 10.91 |
| Jumlah Dagangan | 1,266,442 |
| Purata Dagangan (3B) | 1,368,470 |
| Modal Pasaran | 1,109,263,872 |
| Harga / Buku (P/B) | 2.83 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 Nov 2025 |
| EPS Cair (TTM) | -1.88 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.97% |
| Nisbah Semasa (MRQ) | 12.00 |
| Aliran Tunai Operasi (OCF TTM) | -115.01 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -68.48 M |
| Pulangan Atas Aset (ROA TTM) | -30.87% |
| Pulangan Atas Ekuiti (ROE TTM) | -48.45% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Oric Pharmaceuticals, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.38 |
|
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 7.93% |
| % Dimiliki oleh Institusi | 102.70% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Nextech Invest, Ltd. | 30 Sep 2025 | 7,162,637 |
| Nextech Invest Ltd. | 31 Dec 2024 | 5,285,714 |
| Column Group Llc | 30 Sep 2025 | 3,540,777 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 25.00 (Evercore ISI Group, 119.49%) | Beli |
| Median | 19.50 (71.20%) | |
| Rendah | 15.00 (Oppenheimer, 31.69%) | Beli |
| Purata | 19.67 (72.70%) | |
| Jumlah | 6 Beli | |
| Harga Purata @ Panggilan | 12.03 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Evercore ISI Group | 20 Nov 2025 | 25.00 (119.49%) | Beli | 11.48 |
| JP Morgan | 18 Nov 2025 | 20.00 (75.59%) | Beli | 11.90 |
| Citigroup | 17 Nov 2025 | 16.00 (40.47%) | Beli | 12.06 |
| HC Wainwright & Co. | 14 Nov 2025 | 23.00 (101.93%) | Beli | 12.25 |
| Oppenheimer | 14 Nov 2025 | 15.00 (31.69%) | Beli | 12.25 |
| Wells Fargo | 14 Nov 2025 | 19.00 (66.81%) | Beli | 12.25 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |